Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 11 9 2020
medline: 11 9 2020
entrez: 10 9 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32908251
doi: 10.1038/s41591-020-1079-x
pii: 10.1038/s41591-020-1079-x
pmc: PMC7479399
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1663

Commentaires et corrections

Type : ErratumFor

Auteurs

Adam G Laing (AG)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Anna Lorenc (A)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Irene Del Molino Del Barrio (I)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
UCL Cancer Institute, University College London, London, UK.

Abhishek Das (A)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
London School of Hygiene & Tropical Medicine, London, UK.

Matthew Fish (M)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Leticia Monin (L)

The Francis Crick Institute, London, UK.

Miguel Muñoz-Ruiz (M)

The Francis Crick Institute, London, UK.

Duncan R McKenzie (DR)

The Francis Crick Institute, London, UK.

Thomas S Hayday (TS)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Isaac Francos-Quijorna (I)

Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UK.

Shraddha Kamdar (S)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Magdalene Joseph (M)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Daniel Davies (D)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Department of Plastic and Reconstructive Surgery, Royal Free NHS Foundation Trust, London, UK.

Richard Davis (R)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Aislinn Jennings (A)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Iva Zlatareva (I)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Pierre Vantourout (P)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Yin Wu (Y)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
UCL Cancer Institute, University College London, London, UK.
The Francis Crick Institute, London, UK.

Vasiliki Sofra (V)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Florencia Cano (F)

The Francis Crick Institute, London, UK.

Maria Greco (M)

The Francis Crick Institute, London, UK.

Efstathios Theodoridis (E)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Joshua Freedman (J)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Sarah Gee (S)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Julie Nuo En Chan (JNE)

Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.

Sarah Ryan (S)

Department of Inflammation Biology, King's College London, London, UK.

Eva Bugallo-Blanco (E)

Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.

Pärt Peterson (P)

Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Kai Kisand (K)

Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Liis Haljasmägi (L)

Molecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Loubna Chadli (L)

Center for Therapeutic Innovation in Immuno-inflammation, Servier, France.

Philippe Moingeon (P)

Center for Therapeutic Innovation in Immuno-inflammation, Servier, France.

Lauren Martinez (L)

Infectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Blair Merrick (B)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Karen Bisnauthsing (K)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Kate Brooks (K)

Infectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Mohammad A A Ibrahim (MAA)

Immunological Medicine, Kings College Hospital NHS Foundation Trust, London, UK.

Jeremy Mason (J)

The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.

Federico Lopez Gomez (F)

The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.

Kola Babalola (K)

The European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.

Sultan Abdul-Jawad (S)

Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.

John Cason (J)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Infectious Diseases Biobank, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.

Christine Mant (C)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Infectious Diseases Biobank, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.

Jeffrey Seow (J)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.

Carl Graham (C)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.

Katie J Doores (KJ)

Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.

Francesca Di Rosa (F)

Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy.

Jonathan Edgeworth (J)

Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Manu Shankar-Hari (M)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. manu.shankar-hari@kcl.ac.uk.
Department of Intensive Care Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK. manu.shankar-hari@kcl.ac.uk.

Adrian C Hayday (AC)

Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.
The Francis Crick Institute, London, UK. adrian.hayday@kcl.ac.uk.

Classifications MeSH